Safety of celecoxib in individuals allergic to sulfonamide: A pilot study

Drug Safety

Volumn 26, Issue 3, 2003, Pages 187-195

  Shapiro, Lori E ^a,b,c   Knowles, Sandra R ^a,b   Weber, Elizabeth ^a   Neuman, Manuela G ^b   Shear, Neil H ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CHLOROTHIAZIDE; COTRIMOXAZOLE; FUROSEMIDE; SULFONAMIDE;

ADULT; AGED; ALLERGIC REACTION; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIMICROBIAL ACTIVITY; ARTHRALGIA; ARTHRITIS; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXICITY; DIARRHEA; DRUG CROSS REACTIVITY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DYSPEPSIA; DYSPNEA; FEMALE; FEVER; HEADACHE; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; LIVER MICROSOME; MALAISE; MALE; PAIN; PILOT STUDY; PRICK TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROVOCATION TEST; PRURITUS; RASH; RISK ASSESSMENT; SEIZURE; SKIN TEST; STEVENS JOHNSON SYNDROME; THROMBOCYTOPENIA; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VERTIGO;

ADMINISTRATION, ORAL; ADULT; AGED; ANTI-INFECTIVE AGENTS; CROSS REACTIONS; CYCLOOXYGENASE INHIBITORS; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PYRAZOLES; SKIN TESTS; SULFONAMIDES; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0347926565     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200326030-00004     Document Type: Article

References (39)

1. Hawkey CJ. Cox-2 inhibitors. Lancet 1999; 353: 307-14
2. Koch WJ, Sidel VW, Dexter M, et al. Adverse reactions to sulfisoxazole, sulfamethoxazole and nitrofuranloin: manifestations and specific reaction rales during 2118 courses of therapy. Arch Intern Med 1971; 128: 399-404
3. Sullivan TJ. Cross-reactions among furosemide, hydrochlorothiazide and sulfonamides. JAMA 1991; 265: 120-1
4. Knowles S, Shapiro L, Shear NH. Should celecoxib be contra-indicated in patients who are allergic to sulfonantides? Revisiting the meaning of 'sulfa' allergy. Drug Saf 2001; 24 (4): 239-47
5. Hansbrough JR, Wedner HJ, Chaplin DD. Anaphylaxis to intravenous furosemide. J Allergy Clin Immunol 1987; 80: 538-41
6. Sullivan TJ. Cross-reactions among furosemide, hydrochlorothiazide and sulfonamides. JAMA 1991; 265: 120-1
7. Barrio M, Tomero P, Baeza M. et al. Cross-reactivity among the para-amine group in sulfonamide-induced urticaria and fixed drug eruption [abstract]. J Allergy Clin Immunol 1991; 87: 364A
8. Stock JG. Sulfonamide hypersensitivity and acetazolamide. Arch Ophthalmol 1990; 108: 634-5
9. Schnewweiss F. Cross-sensitivity between sulfonamides and furosemide [letter]. Clin Pharm 1983; 2: 510
10. Stock JG. Sulfonamide hypersensitivity and acetazolamide. Arch Ophthalmol 1990; 108: 634-5
11. Stricker B, Biriell C. Skin reactions and fever with indapamide. BMJ 1987; 295: 1313-4
12. De Bamo M, Tornero P, Zubeldia JM, et al. Fixed drug eruption induced by indapamide: cross reactivily with sulfonamides. J Investig Allergol Clin Immunol 1998; 8: 253-5
13. Shenfield GM, Jacka J. Adverse drug reaction [letter]. Lancet 2001; 57: 561
14. Bretza J. Thrombocytopenia due to sulfonamide cross-sensitivity. Wis Med J 1982; 81: 21-3
15. Shenfield GM, Jacka J. Adverse drug reactions [letter]. Lancet 2001; 357: 561
16. Britschgi M, Steiner U, Schmid S, et al. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest 2001; 107: 1433-41
17. Neuman MG, Malkiewicz IM, Shear NH. A novel lymphocyte toxicity assay to assess drug hypersensitivity syndromes. Clin Biochem 2000 Oct; 33 (7): 517-24
18. Weber EA, Uetrecht JP, Knowles SR, et al. Detection of sulfamethoxazole hypersensitivity: skin testing with sulfamethoxazoyl-poly-L-tyrosine [abstract]. J Allergy Clin Immunol 1994; 93: 623A
19. Gruchalla R, Sullivan T. Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazoly-poly-L-tyrosine. J Allergy Clin Immunol 1991; 88: 784-92
20. Spielberg SP. Acetaminophen toxicity in human lymphocytes in vitro. J Pharmacol Exp Ther 1980; 213: 395-8
21. Harle DG, Baldo BA. Wells JV. Drugs as allergens: detection and combining site specificities of IgE antibodies to sulfamethoxazole. Mol Immunol 1988; 25: 1347-54
22. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome: in vitro assessment of risk. J Clin Invest 1988; 82: 1826-32
23. Knowles SR. Shapiro L, Shear NH. Serious adverse drug reactions induced by minocycline: report of 13 patients and review of the literature. Arch Dermatol 1996; 132: 934-9
24. Rieder M, Uetrecht J, Shear NH, et al. Diagnosis of sulfonamide hypersensitivity reactions by in-vitro 'rechallenge' with hydroxylamine melabolites. Ann Intern Med 1989; 110: 286-9
25. Rieder M, Ueterecht J, Shear NH, et al. Diagnosis of sulfonamide hypersensitivity reactions by in vitro 'rechallenge' with hydroxylamine metabolites. Ann Intern Med 1989; 110: 286-9
26. Cribb A, Spielberg S. Hepatic microsomal melabolism of sulfamethoxazole to the hydroxylamine. Drug Metab Dispos 1990; 18: 784-7
27. Cribb A, Spielberg S, Griffin G. N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes. Drug Metab Dispos 1995; 23: 406-14
28. Cribb A, Miller M, Leeder J, et al. Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Drug Metab Dispos 1991; 19: 900-6
29. Spielberg SP, Leeder JS, Cribb AE, et al. Is sulfamethoxazole hydroxylamine the proximal toxin for sulfamethoxazole toxicity? Eur J Clin Pharmacol 1989; A173: 04: 37
30. Rieder MJ, Uetrecht J, Shear NH, et al. Diagnosis of sulfonamide hypersensitivity reactions by in vitro 'rechallenge' with hydroxylamine metabolites. Ann Intern Med 1989; 110 (4): 286-9
31. Naisbitt DJ, Hough SJ, Gill HJ, et al. Cellular disposition of sulfamethoxazole and its metabolites: implications for hypersensitivity. Br J Pharmacol 1999 Mar: 12: 1393-407
32. Cribb AE, Lee BL, Trepanier LA, et al. Adverse reactions to sulfonamide and sulfonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis. Adverse Drug React Toxicol Rev 1996 Mar; 1: 9-50
33. Shapiro LE, Neuman MG, Malkiewicz I, et al. Assessment of sulfonamide-induced hypersensitivity syndrome reactions with the use of a novel lymphocyte toxicity assay: preliminary results. Clin Invest Med 1998; 21: Suppl. 15: A571
34. Neuman MG, Shapiro LE, Phillips E, et al. Lymphocyte toxicity test as a predictor of hypersensitivity reactions in immunocompetent and immunocompromised populations [abstract]. Ther Drug Monit 1999; 21: 453
35. Neuman MG, Malkiewicz IM, Shear NH. A novel lymphocyte toxicity assay to assess drug hypersensitivity syndromes. Clin Biochem 2000 Oct; 33 (7): 517-24
36. Newman LC, Lay CL, O'Connor KA, et al. Lack of crossreactivity to sumatriptan in patients allergic to sulfonamides: a retrospective chart review [letter]. Headache 1999; 39: 372
37. Patterson R, Bello AE, Lefkowith J. Immunologic tolerability profile of celecoxib. Clin Ther 1999 Dec; 21: 2065-79
38. Wilholm BE. Identification of sulfonamide-like adverse drug reactions to celecoxib in the World Health Organizaion database. Curr Med Res Opin 2001; 17: 210-6
39. Weber EA, Knight A. Testing for allergy to antibiotics. Semin Dermatol 1989; 8: 204-12